BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8058185)

  • 1. [Calcium antagonists and heart failure. Critical review of the literature].
    Devigili G
    Minerva Cardioangiol; 1994 Apr; 42(4):177-89. PubMed ID: 8058185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists and left ventricular function.
    Heywood JT
    Am J Cardiol; 1991 Nov; 68(12):52C-57C. PubMed ID: 1951104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
    Packer M; Kessler PD; Lee WH
    Circulation; 1987 Jun; 75(6 Pt 2):V56-64. PubMed ID: 3552317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure in patients with normal left ventricular systolic function: a manifestation of diastolic dysfunction.
    Gaasch WH
    Herz; 1991 Feb; 16(1):22-32. PubMed ID: 1673955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of heart failure with calcium antagonists].
    Hall D; Dirschinger J; Kraus F; Rudolph W
    Herz; 1990 Jun; 15(3):179-84. PubMed ID: 2198218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].
    de Sá ME
    Rev Port Cardiol; 1989; 8(7-8):547-52. PubMed ID: 2698718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving role of calcium channel blockers in heart failure.
    Pieper JA
    Pharmacotherapy; 1996; 16(2 Pt 2):43S-49S. PubMed ID: 8668605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure.
    Hung MJ; Cherng WJ; Kuo LT; Wang CH
    Int J Clin Pract; 2002; 56(1):57-62. PubMed ID: 11831838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
    Gattis W; O'Connor CM
    Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release calcium channel antagonists in cardiovascular disease: pharmacology and current therapeutic use.
    Silvestry FE; St John Sutton MG
    Eur Heart J; 1998 Aug; 19 Suppl I():I8-14. PubMed ID: 9743438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure caused by severe systolic ventricular dysfunction of hypertensive origin. Long-term clinical and functional course].
    Anguita M; Castillo JC; Ramírez A; Siles JR; Ojeda S; Mesa D; Franco M; Vallés F
    Rev Esp Cardiol; 2000 Jul; 53(7):927-31. PubMed ID: 10944991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
    Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diuretics in the treatment of heart failure: current pathophysiological aspects].
    Mandinov L; Matter C; Kaufmann P; Hess OM
    Praxis (Bern 1994); 1997 Apr; 86(14):575-82. PubMed ID: 9198852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists in cardiomyopathy].
    Takabatake Y
    Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heart failure due to diastolic dysfunction: the treatment principles].
    Pinamonti B; di Lenarda A; Sinagra G
    Ital Heart J Suppl; 2000 Apr; 1(4):469-80. PubMed ID: 10832133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.